Retatrutide is a new weight loss peptide currently in clinical trials.

It’s designed to help people lose weight by targeting several pathways in the body at once.

Studies are showing that 26% of patients are losing as much of 30% or more of their base weight.

The early trial results have been promising, with some participants seeing significant weight loss.

But how do you get it? Let’s dive into the details.

What Conditions Could Retatrutide Treat?

Drug developers and healthcare providers hope that retatrutide will be a novel, highly effective treatment for :

1. Type 2 diabetes

2. Obesity

3. Fatty Liver Disease

Fatty liver disease is a common but reversible condition linked to obesity, alcoholism, and type 2 diabetes. In this condition, fat builds up in your liver, making it harder for your liver to complete its normal functions of:

• Removing toxins from your blood

    Digesting food

    Storing energy

    Notably, participants in the Phase 2 Clinical Trials of retatrutide also reported healthy changes in their hemoglobin A1c (a measure of diabetes control), blood pressure, and LDL (unhealthy) cholesterol as they lost weight.